Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
暂无分享,去创建一个
D. Nagel | Peter A. Knight | Faqian Li | Katherine D. Cygnar | Qian Zhou | Yujun Cai | Haiqing Zhao | Xinchun Pi | C. Yan
[1] R. Virmani,et al. TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling , 2014, Science Translational Medicine.
[2] S. Rafii,et al. Maladapted Endothelial Cells Flip the Mesenchymal Switch , 2014, Science Translational Medicine.
[3] W. Knight,et al. Therapeutic potential of PDE modulation in treating heart disease. , 2013, Future medicinal chemistry.
[4] T. Kohno,et al. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury. , 2013, American journal of physiology. Cell physiology.
[5] Chi-Tan Hu,et al. The role of endosomal signaling triggered by metastatic growth factors in tumor progression. , 2013, Cellular signalling.
[6] Chen Yan,et al. Thioredoxin-Interacting Protein Mediates Sustained VEGFR2 Signaling in Endothelial Cells Required for Angiogenesis , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[7] Julie H. Campbell,et al. Smooth muscle cell plasticity: fact or fiction? , 2013, Circulation research.
[8] C. Yan,et al. Cardiac Cyclic Nucleotide Phosphodiesterases: Function, Regulation, and Therapeutic Prospects , 2012, Hormone and Metabolic Research.
[9] S. Chan,et al. PDE1 isozymes, key regulators of pathological vascular remodeling. , 2011, Current opinion in pharmacology.
[10] W. Taki,et al. Tenascin‐C enhances crosstalk signaling of integrin αvβ3/PDGFR‐β complex by SRC recruitment promoting PDGF‐induced proliferation and migration in smooth muscle cells , 2011, Journal of cellular physiology.
[11] Clint L. Miller,et al. Cyclic Nucleotide Phosphodiesterase 1 Regulates Lysosome-Dependent Type I Collagen Protein Degradation in Vascular Smooth Muscle Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[12] Qingbo Xu,et al. Resident vascular progenitor cells. , 2011, Journal of molecular and cellular cardiology.
[13] J. Herz,et al. Lipoprotein receptors – an evolutionarily ancient multifunctional receptor family , 2010, Biological chemistry.
[14] L. Pendyala,et al. The first-generation drug-eluting stents and coronary endothelial dysfunction. , 2009, JACC. Cardiovascular interventions.
[15] Y. Takayama,et al. LRP1 Regulates Architecture of the Vascular Wall by Controlling PDGFRβ-Dependent Phosphatidylinositol 3-Kinase Activation , 2009, PloS one.
[16] V. Korshunov,et al. Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[17] Morag Park,et al. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. , 2009, American journal of physiology. Endocrinology and metabolism.
[18] C. Sato,et al. Characterization of phosphodiesterase 1 in human malignant melanoma cell lines. , 2009, Anticancer research.
[19] Haiqing Zhao,et al. Phosphodiesterase 1C is dispensable for rapid response termination of olfactory sensory neurons , 2009, Nature Neuroscience.
[20] Gordon B. Mills,et al. Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.
[21] D. Strickland,et al. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. , 2008, Physiological reviews.
[22] Gengsheng Chen,et al. Binding of Cbl to a Phospholipase Cγ1-docking Site on Platelet-derived Growth Factor Receptor β Provides a Dual Mechanism of Negative Regulation* , 2007, Journal of Biological Chemistry.
[23] P. Libby,et al. Vascular remodeling in transplant vasculopathy. , 2007, Circulation research.
[24] C. Söderberg-Nauclér,et al. Human Cytomegalovirus Downregulates Expression of Receptors for Platelet-Derived Growth Factor by Smooth Muscle Cells , 2007, Journal of Virology.
[25] D. Nagel,et al. Role of Nuclear Ca2+/Calmodulin-Stimulated Phosphodiesterase 1A in Vascular Smooth Muscle Cell Growth and Survival , 2006, Circulation research.
[26] S. Eddahibi,et al. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties. , 2006, The Journal of thoracic and cardiovascular surgery.
[27] J. Beavo,et al. PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Weiss,et al. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells , 2005, The Journal of experimental medicine.
[29] Jeffrey W. Streb,et al. Cross-species Sequence Analysis Reveals Multiple Charged Residue-rich Domains That Regulate Nuclear/Cytoplasmic Partitioning and Membrane Localization of A Kinase Anchoring Protein 12 (SSeCKS/Gravin)* , 2005, Journal of Biological Chemistry.
[30] E. Loukinova,et al. Platelet-derived Growth Factor Receptor-β (PDGFR-β) Activation Promotes Its Association with the Low Density Lipoprotein Receptor-related Protein (LRP) , 2005, Journal of Biological Chemistry.
[31] Richard G. W. Anderson,et al. Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Controls Endocytosis and c-CBL-mediated Ubiquitination of the Platelet-derived Growth Factor Receptor β (PDGFRβ)* , 2005, Journal of Biological Chemistry.
[32] J. Beavo,et al. Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] G. Owens,et al. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.
[34] Salvatore Pece,et al. Endocytosis and cancer. , 2004, Current opinion in cell biology.
[35] M. Gotthardt,et al. LRP and PDGF signaling: a pathway to atherosclerosis. , 2004, Trends in cardiovascular medicine.
[36] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[37] B. Berk,et al. Flow-Induced Vascular Remodeling in the Mouse: A Model for Carotid Intima-Media Thickening , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[38] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[39] Richard G. W. Anderson,et al. LRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis , 2003, Science.
[40] S. Schwartz,et al. Expression Profiling Identifies 147 Genes Contributing to a Unique Primate Neointimal Smooth Muscle Cell Phenotype , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[41] C. Klein. Nitric oxide and the other cyclic nucleotide. , 2002, Cellular signalling.
[42] Richard G. W. Anderson,et al. Platelet-derived Growth Factor Mediates Tyrosine Phosphorylation of the Cytoplasmic Domain of the Low Density Lipoprotein Receptor-related Protein in Caveolae* , 2002, The Journal of Biological Chemistry.
[43] Sripriya Ranganathan,et al. Platelet-derived Growth Factor (PDGF)-induced Tyrosine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein (LRP) , 2002, The Journal of Biological Chemistry.
[44] M. Makuuchi,et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.
[45] J. Beavo,et al. Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation , 2002, Circulation research.
[46] A. Chiavegato,et al. Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.
[47] S. Nishikawa,et al. Functional Blockade of Platelet-Derived Growth Factor Receptor-&bgr; but Not of Receptor-&agr; Prevents Vascular Smooth Muscle Cell Accumulation in Fibrous Cap Lesions in Apolipoprotein E–Deficient Mice , 2001, Circulation.
[48] Yonghe Li,et al. Identification of a Major Cyclic AMP-Dependent Protein Kinase A Phosphorylation Site within the Cytoplasmic Tail of the Low-Density Lipoprotein Receptor-Related Protein: Implication for Receptor-Mediated Endocytosis , 2001, Molecular and Cellular Biology.
[49] S. Fukumoto,et al. Molecular pathways of cyclic nucleotide‐induced inhibition of arterial smooth muscle cell proliferation , 2001, Journal of cellular physiology.
[50] M. Schwartz,et al. Cell Adhesion Regulates Ubiquitin-mediated Degradation of the Platelet-derived Growth Factor Receptor β* , 2000, The Journal of Biological Chemistry.
[51] M. Makuuchi,et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. , 2000, Journal of molecular and cellular cardiology.
[52] C. Mullany,et al. The role of gene therapy for intimal hyperplasia of bypass grafts. , 1999, Circulation.
[53] B. M. Mueller,et al. Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. , 1998, The Biochemical journal.
[54] Qingbo Xu,et al. Mouse model of venous bypass graft arteriosclerosis. , 1998, The American journal of pathology.
[55] E. Krebs,et al. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. , 1997, The Journal of clinical investigation.
[56] Amit Kumar,et al. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[57] B. M. Mueller,et al. Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase. , 1997, Journal of cell science.
[58] J. Isner,et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. , 1997, Circulation.
[59] J. Beavo,et al. The Calmodulin-dependent Phosphodiesterase Gene PDE1C Encodes Several Functionally Different Splice Variants in a Tissue-specific Manner* , 1996, The Journal of Biological Chemistry.
[60] J. Beavo,et al. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.
[61] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[62] Gengsheng Chen,et al. Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation. , 2007, The Journal of biological chemistry.
[63] M. Krainer,et al. Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. , 2007, The international journal of biochemistry & cell biology.
[64] Richard G. W. Anderson,et al. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta). , 2005, The Journal of biological chemistry.
[65] J. Moses,et al. Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery , 2004 .
[66] A. Halayko,et al. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. , 2001, Journal of applied physiology.
[67] A. Halayko,et al. Invited Review: Molecular mechanisms of phenotypic plasticity in smooth muscle cells , 2001 .
[68] T. Ashikaga,et al. Phosphodiesterases in vascular endothelial cells. , 1992, Advances in second messenger and phosphoprotein research.
[69] C. Lugnier,et al. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. , 1990, Biochemical pharmacology.